HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Andrew R. Blight, Ph.D., Chief Scientific Officer, has been invited to deliver the G. Heiner Sell Memorial Lecture at the opening plenary session of the American Spinal Injury Association (ASIA) 36th Annual Scientific Meeting on May 26, 2010. He will address the biotechnology and pharmaceutical industry perspective on spinal cord injury as a target for therapeutic development.
